Dr. Anupam Sehgal
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| First-in-Human Study of TSHA-101 Gene Therapy for Treatment of Infantile Onset GM2 Gangliosidosis (NCT04798235) | Dr. Anupam Sehgal | 2021-03-12 |
Track Dr. Anupam Sehgal automatically
Every clearance here is in the API, with alerts when new ones post.